Drug intelligence / Profile preview

lithium + topiramate

Development stage
Preclinical
Lead developer
Janssen Pharmaceutical
Administration
Oral
01

Overview

The combination of lithium and topiramate represents a drug interaction rather than a single formulated product. This combination is sometimes used in psychiatric treatment, particularly for mood disorders, but requires careful monitoring due to potential interactions. Lithium is a mood stabilizer primarily used to treat bipolar disorder, while topiramate (brand names include Topamax, Trokendi XR, Qudexy XR, and Eprontia) is an anticonvulsant that has multiple uses including seizure management, migraine prevention, and as an adjunct for weight loss. ## Interaction Mechanism When used together, topiramate can significantly affect lithium levels in the body. Elevated and toxic lithium levels have been reported with higher doses of topiramate (800 mg/day), though not consistently with lower doses (500 mg/day)[2][8]. The mechanism appears to involve topiramate's effect on renal function, as lithium is eliminated by the kidney for about 95%, and changes in excretion rate can cause unwanted effects[2]. ## Clinical Considerations This combination requires careful monitoring as it may have both beneficial and harmful effects: - **Potential Benefits**: The combination may have synergistic therapeutic effects for mood stabilization[2]. - **Risks**: The combination can lead to additive side effects and potentially lithium toxicity[2][8]. ## Monitoring Requirements When lithium and topiramate are used together: - Pharmacologic response and serum lithium levels should be monitored closely, particularly after changes in topiramate dosage or discontinuation[2]. - Lithium levels should be monitored when co-administered with high-dose topiramate[6]. ## Case Reports There have been documented cases of lithium toxicity following the administration of topiramate. One case report describes a 47-year-old man with schizoaffective disorder who developed symptoms of lithium toxicity on the fourth day of topiramate treatment, which was added to address compulsive consumption of food and liquids. The patient required emergency treatment for renal insufficiency due to lithium toxicity[8]. ## Dosing Considerations When adding topiramate to lithium therapy, dose adaptation is recommended[2]. Topiramate should be started according to general dosing advice, with careful monitoring of lithium levels[2]. This combination should be approached with caution, and healthcare providers should weigh the potential benefits against the risks of interaction when considering this treatment approach.

02

Targets

GSK3 (Glycogen synthase kinase 3 beta)INPP1 (Inositol polyphosphate 1-phosphatase)GABRR (GABA-A receptor subunit rho)iGluR (Ionotropic receptor 76b (Ir76b))CA4 (Carbonic anhydrase 4)CA2 (Carbonic Anhydrase 2)BPNT1 (3'(2'),5'-bisphosphate nucleotidase 1)NaV (Voltage-gated sodium channels)IMPA1 (Inositol Monophosphatase)

Beyond the preview

Go deeper on lithium + topiramate.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on lithium + topiramate.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call